Congress Asset Management Co. Has $178.14 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Congress Asset Management Co. reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 314,531 shares of the medical equipment provider’s stock after selling 4,955 shares during the quarter. Intuitive Surgical comprises 1.3% of Congress Asset Management Co.’s holdings, making the stock its 13th biggest position. Congress Asset Management Co. owned 0.09% of Intuitive Surgical worth $178,138,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. Brighton Jones LLC boosted its stake in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the last quarter. Sivia Capital Partners LLC raised its position in shares of Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after acquiring an additional 34 shares during the last quarter. Schnieders Capital Management LLC. raised its position in shares of Intuitive Surgical by 38.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after acquiring an additional 268 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at $394,000. Finally, AlphaCore Capital LLC lifted its stake in shares of Intuitive Surgical by 40.6% in the 2nd quarter. AlphaCore Capital LLC now owns 1,088 shares of the medical equipment provider’s stock valued at $591,000 after purchasing an additional 314 shares during the period. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of analyst reports. Robert W. Baird decreased their price objective on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research note on Friday, January 23rd. Sanford C. Bernstein increased their target price on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Royal Bank Of Canada raised their target price on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price for the company in a research report on Wednesday, March 11th. Finally, UBS Group cut their price target on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 17th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $614.95.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the transaction, the vice president owned 660 shares of the company’s stock, valued at approximately $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Mark Brosius sold 645 shares of the stock in a transaction on Monday, March 9th. The stock was sold at an average price of $485.01, for a total transaction of $312,831.45. Following the sale, the senior vice president directly owned 1,613 shares of the company’s stock, valued at $782,321.13. This represents a 28.57% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 32,943 shares of company stock valued at $17,279,568. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Trading Up 0.0%

NASDAQ:ISRG opened at $478.04 on Tuesday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $603.88. The stock has a 50-day moving average price of $500.94 and a two-hundred day moving average price of $513.62. The stock has a market cap of $169.77 billion, a price-to-earnings ratio of 60.59, a PEG ratio of 3.69 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the previous year, the business posted $2.21 EPS. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.